M
Monopar Therapeutics Inc. (MNPR)
NCM – Real vaqt narxi. Valyuta: USD
61.35
-4.17 (-6.36%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
61.35
-4.17 (-6.36%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Monopar Therapeutics Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda saratonni davolash uchun terapevtik vositalarni ishlab chiqish bilan shug'ullanadi. Kompaniya ALXN1840, kechki bosqichdagi, kuniga bir marta og'iz orqali qabul qilinadigan dori vositasini; MNPR-101, urokinaz plazminogen aktivator retseptorlarini ifoda etuvchi rivojlangan qattiq o'smalarni davolash uchun turli xil radioizotoplar bilan kon'yugatsiyalangan patentlangan insonlashtirilgan monoklonal antitanani; va MNPR-101-Zr, fazasi 1 tasvirga olish va doza o'lchash klinik sinovida bo'lgan, MNPR-101 ni zirkonyum-89 bilan kon'yugatsiyalangan radioterapiya tasvir vositasini ishlab chiqadi. Kompaniya MNPR-101-Lu, aktiniy-225 bilan kon'yugatsiyalangan fazasi 1a radioterapiya vositasini ishlab chiqadi. Kompaniya og'ir COVID-19 ni maqsad qilib olgan radioimmunoterapiyalarni ishlab chiqish bo'yicha NorthStar bilan hamkorlik qiladi; Excel Diagnostics and Nuclear Oncology Center bilan MNPR-101-Zr tasvirga olish vositasi va MNPR-101-Lu terapevtik vositasi uchun; Uilson kasalligini davolash uchun dori nomzodi bo'lgan ALXN1840ni ishlab chiqish va tijoratlashtirish uchun Alexion bilan litsenzion kelishuvga ega. Kompaniya 2014-yilda tashkil etilgan va Illinoys shtatining Uilmet shaharchasida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Chandler D. Robinson M.B.A., M.D., M.Sc. | Co-Founder, CEO, President & Director |
| Dr. Christopher M. Starr Ph.D. | Co-Founder & Independent Executive Chairman of the Board |
| Dr. Patrice P. Rioux M.D., Ph.D. | Acting Chief Medical Officer |
| Mr. Andrew J. Cittadine M.B.A. | Chief Operating Officer |
| Mr. Quan Anh Vu | CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer |
| Ms. Susan Rodriguez |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | DEF 14A | mnpr20260330_def14a.htm |
| 2026-04-20 | 8-K | mnpr20260419_8k.htm |
| 2026-04-01 | 10-K/A | mnpr20251231c_10ka.htm |
| 2026-03-27 | 10-K | mnpr20251231_10k.htm |
| 2026-03-02 | 8-K | mnpr20260302_8k.htm |
| 2025-11-13 | 8-K | mnpr20251105_8k.htm |
| 2025-11-10 | 8-K | mnpr20251108_8k.htm |
| 2025-09-24 | 8-K | mnpr20250924_8k.htm |
| 2025-09-15 | 8-K | mnpr20250912_8k.htm |
| 2025-09-05 | CORRESP | filename1.htm |
| Chief Commercial & Strategy Officer |